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Abstract 
Background: Deep invasion of the normal surrounding tissue by primary cervical cancers is a prognostic parameter 
for postoperative radiotherapy and relatively worse survival. However, patients with tumor-specific immunity in the 
blood at the time of surgery displayed a much better disease free survival. Here we analyzed if this was due to a more 
tumor-rejecting immune population in the tumor.
Methods: Tumor sections from a group of 58 patients with deep normal tissue-invading cervical tumors were 
stained for the presence of immune cells (CD45), IFNγ-producing cells (Tbet) and regulatory T cells (Foxp3) by immu-
nohistochemistry. The slides were scanned and both the tumor area and the infiltration of the differently stained 
immune cells were objectively quantified using computer software.
Results: We found that an increased percentage of tumor occupied by CD45+ cells was strongly associated with 
an enhanced tumor-infiltration by Tbet+ cells and Foxp3+ cells. Furthermore, the area occupied by CD45+ immune 
cells, Tbet+ cells but not Foxp3+ cells within the tumor were, in addition to the lymph node status of patients, associ-
ated with a longer disease free survival and disease specific survival. Moreover, interaction analyses between these 
immune parameters and lymph node status indicated an independent prognostic effect of tumor infiltrating Tbet+ 
cells. This was confirmed in a multivariate Cox analysis.
Conclusions: The area occupied by a preferentially type I oriented CD45+ cell infiltrate forms an independent prog-
nostic factor for recurrence-free and disease-specific survival on top of the patient’s lymph node status.
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Background
Cervical cancer (CxCa) develops as a result of an uncon-
trolled, persistent infection with a high-risk type of 
human papillomavirus (HPV), in particular types HPV16 
and HPV18 [1]. The HPV genome encodes two oncopro-
teins, E6 and E7, which are constitutively expressed as 
they are required for the onset and maintenance of the 
malignant cellular phenotype [2]. These viral proteins 
form excellent targets for the immune system. Indeed 
HPV16-specific T cell responses are frequently detected 
in the blood of healthy individuals from which these 
cells can migrate upon antigenic challenge, showing that 
a successful defense against HPV is associated with sys-
temically detectable T-cell responses against these viral 
antigens [3].
Previously, we have performed the largest prospective 
study on the HPV-specific immune response in relation 
to clinical prognostic factors in a group of 119 patients 
with HPV-induced CxCa. Proliferative T-cell reactivity 
against the HPV E6 and E7 oncoproteins was detected in 
the blood of about one-third of that group, most promi-
nently in the group of patients with a tumor that deeply 
(≥15 mm) penetrated the healthy surrounding tissue [4]. 
Surprisingly, while deep invasion generally is associated 
with poor clinical outcome of CxCa [5], the patients dis-
playing HPV-specific T cell reactivity in their blood had 
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a significantly better 3-year disease free survival [4]. Ani-
mal studies have shown that the systemic spread of spon-
taneously-induced tumor-specific T cells requires local 
activation [6–8], suggesting that the detection of circulat-
ing tumor-specific T cells may represent a locally active 
immune population in the tumor microenvironment. 
This hypothesis is supported by a small study on HPV18-
induced high grade cervical lesions where the number 
of lesion-infiltrating IFNγ-producing immune cells was 
found to be associated with the presence of HPV18-spe-
cific IFNγ-producing T cells in the blood [9].
Studies on the microenvironment of HPV-induced 
CxCa showed that decreased expression of the tumor-
expressed T-cell ligands human leukocyte antigen class I 
and MHC class I chain-related molecule A had a negative 
impact on disease specific survival [10]. In contrast, the 
infiltration with high numbers of CD8+ T cells and rela-
tively low numbers of CD4+ regulatory T cells (Tregs), 
as indicated by the expression of intra-nuclear FoxP3, 
is associated with better survival [10, 11]. Furthermore, 
a dense infiltration with tumor-infiltrating type 1 (M1) 
macrophages also was associated with improved disease-
specific survival. Notably both the CD8+ to regulatory 
T-cell ratio and the number of M1 macrophages are inde-
pendent prognostic factors for survival in CxCa [12]. The 
analyses of many different tumors revealed that strong 
infiltration with an activated type 1 T cell signature, 
reflected by the local expression of amongst others IFNγ/
Tbet and granzymes, was associated with better prog-
nostic outcome, better response to therapy or a higher 
chance to have a complete regression [13]. Expression of 
granzyme B has been detected in about 30 % of a small 
group of CxCa [14]. In addition, the expression of the 
programmed cell death receptor 1 was detected at the 
surface of about 50  % of the tumor-infiltrating CD4+ 
and CD8+ T cells [15] where it’s expression may reflect 
exhausted as well as activated T cells [16, 17]. Further-
more, the presence of M1 macrophages in a subgroup 
of patients suggest the local presence of IFNγ as this is 
required for the optimal polarization in the local tumor 
milieu [18]. Altogether this suggests that some CxCa 
patients have tumors with a more favorable immune 
microenvironment.
In order to study if some of the deep normal tissue-
invading tumors are highly immunologically active and 
associated with a better clinical outcome, a group of 58 
patients was studied with respect to CD45+ cell infil-
tration, the expression of Tbet as a measure for type 1 
T cell signature and the expression of Foxp3 for regula-
tory T cells. We demonstrate that the presence of large 
tumor areas occupied by Tbet positive cells is associated 
with improved recurrence free survival and a lower risk 
of death by deeply invading cervical cancer.
Methods
Patient material
Formalin-fixed, paraffin-embedded (FFPE) CxCa speci-
mens obtained from patients who underwent pri-
mary surgical treatment for CxCa between 1998 and 
2006 with sufficient material available for analysis were 
obtained from the archives of the department of Pathol-
ogy, Leiden University Medical Center (n =  58). Cervi-
cal adenosquamous carcinoma was discriminated from 
squamous cell carcinomas by using periodic acid Schiff 
plus and Alcian blue stainings in addition to a hema-
toxylin and eosin staining [19]. None of the patients had 
received preoperative anticancer therapy and follow-up 
data were obtained from patient medical records. Patient 
and tumor characteristics are listed in Table  1. Patient 
samples were handled according to the medical ethical 
guidelines described in the Code of Conduct for Proper 
Secondary Use of Human Tissue of the Dutch Federation 
of Biomedical Scientific Societies.
Immunohistochemistry
Immunostainings were performed on 4  μm thick FFPE 
sections. Deparaffinized sections were treated with 0.3 % 
H2O2 in methanol for 20  min to block endogenous per-
oxidase activity. After rehydration, antigen retrieval 
Table 1 Patient characteristics
a At time of intervention






 1b1, 1b2 47 81
 2a, 2b 10 17
 Unknown 1
LN metastasesb
 Yes 27 46
 No 31 54
Tumor sizeb
 <4 cm 22 38
 ≥4 cm 36 62
Vasoinvasionb
 Yes 33 57
 No 9 16
 Unknown 16 27
Parametria involvementb
 Yes 9 16
 No 37 64
 Unknown 12 20
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was performed in Tris-ethylenediaminetetraacetic acid 
(EDTA) buffer (10  mM TRIS plus 1  mM EDTA pH 9.0) 
and mouse IgG1 anti-CD45 (clone 2B11+ PD7/26, 
Dako, Glostrup, Denmark) or mouse IgG1 anti-FoxP3 
(clone 236A/E7, Abcam, Cambridge, UK) diluted in 1  % 
w/v bovine serum albumin (BSA) in phosphate buffered 
saline (PBS) was incubated at room temperature over-
night. Subsequently, BrightVision poly-horseradish per-
oxidase (HRP)-anti mouse/rabbit/rat IgG (Immunologic, 
Duiven, The Netherlands) was incubated for 30 min and 
the HRP activity was visualized using 0.5 % 3,3′-diamino-
benzidine-tetrahydrochloride (DAB) and 0.002 % H2O2 in 
TRIS–HCl. After antigen retrieval in citrate buffer pH6.0, 
rabbit anti-T-bet (H-210, Santa Cruz, TX, USA) diluted 
in 1  % BSA in PBS was incubated at room temperature 
overnight, followed by incubation with DAB+ (Dako). 
Sections were counterstained with hematoxylin and slides 
were mounted using CV Mount (Leica Microsystems).
Image analysis
Slides were scanned with a Panoramic Midi auto-
mated slide scanner (3DHISTECH, Budapest, Hun-
gary) with a 20× objective. From the scanned slides the 
tumor area was selected at the same magnification. The 
images were analyzed with ImageJ (1.47v; developed 
by Wayne Rasband, National Institute of Health, MD, 
USA). Colors were separated using the color deconvolu-
tion plugin Haematoxylin and DAB (H DAB), as shown 
in Fig.  1. First, the total tissue area was selected with a 
100 % threshold of the haematoxylin staining (Fig. 1b, d). 
Subsequently, the area occupied by the DAB signal was 
selected using an appropriate threshold level (Fig. 1c, e). 
Both areas were recorded as a number of pixels. The DAB 
area divided by the total tissue area (100×) provides the 
percentage of tissue occupied by DAB positive cells. Rep-
resentative images of the staining at a 200× magnifica-
tion were obtained by using a 40× objective.
Statistics
Statistical analyses were performed using SPSS version 
20.0 (IBM Corp., Armonk, USA). Correlation between 
the area occupied by the different types of DAB-positive 
cells and clinical variables were tested with Pearson’s 
correlation, paired t test and Wilcoxon Mann–Whitney 
tests, as appropriate. Correlation between clinical varia-
bles or immune parameters and disease-specific or recur-
rence-free survival was calculated by the Kaplan–Meier 
method and analyzed by the log-rank test. Univariate and 
multivariate Cox proportional hazards models were used 
to determine the hazard ratio (HR) that represents the 
relative risk of death among patients in the different indi-




In order to study if immunologically active tumors were 
associated with better clinical outcome a group of 58 
women with Figo stage 1b to 2b CxCa was selected based 
on a surrounding tissue infiltration depth of 15  mm 
or more. Patients with Figo stages 1a were not selected 
because they have a near to 100  % survival rate after 
surgery, whereas patients with Figo stages 3 and 4 were 
not selected since they are treated by primary chemora-
diation. Patient characteristics are shown in Table 1. The 
mean age of the 58 patients was 45 years (range 25–87). 
The infiltration depth ranged from 15 to 95  mm (mean 
25). The average tumor size was 50 mm (range 20–130) 
and lymph node metastases were found in 27 patients. 
The great majority was squamous cell carcinoma and 
treated with postoperative radiotherapy. The average 
total follow up time was 57 months (range 2.2–147).
The tumor area occupied by immune cells increases with a 
stronger co‑infiltration of Tbet+ and Foxp3+ cells
We used an objective quantitative automated method 
to analyze immune cell infiltration of tumors (Fig.  1). 
In 52/58 cases tumor sections could be stained for the 
presence of CD45+ cells, the presence of Tbet+ cells, 
as a measure for IFNγ-producing cells, and the pres-
ence of Foxp3+ cells for regulatory T cells. Analyses of 
all tumors using Image J revealed that the mean number 
of pixels representing tumor infiltrating CD45+ cells 
was high (5672 per HPF (20×); range 1613–8572) and 
that these cells occupied on average 17  % of the tumor 
area (range 0.6–58  %). The mean number of pixels rep-
resenting Tbet+ cells was 302 per HPF (range 9–3069) 
and that of Foxp3+ cells was 142 per HPF (range 6–481). 
Figure  2 shows an example of a tumor with high num-
bers of infiltrating immune cells and a tumor with low 
numbers of infiltrating immune cells. Statistical analy-
ses showed that overall (p  <  0.0005; Mann–Whitney) 
but also in each sample (p < 0.0005; paired sample t test) 
the pixel count for tumor-infiltrating CD45+ cells was 
higher than that of Tbet+ cells and that of Foxp3+ cells, 
indicating that these two functional cell types were not 
the only types of immune cells infiltrating the tumor. 
An increase in the total pixel count of tumor-infiltrating 
immune cells was often reflected in higher pixel count for 
Tbet+ (r = 0.267, p = 0.061; Pearson) and Foxp3+ cells 
(r = 0.414, p = 0.005; Pearson). There was a strong posi-
tive correlation between the pixel count of Tbet+ and 
Foxp3+ cells (r = 0.539, p < 0.0005; Pearson) indicating 
that these cell types frequently co-infiltrated the tumor. 
However, the pixel count for tumor-infiltrating Tbet+ 
cells was generally (p < 0.0005; Mann–Whitney) but also 
in each sample (p =  0.011; paired sample t test) higher 
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than that of Foxp3+ cells. Interestingly, the pixel count 
for Tbet+ and Foxp3+ cells positively correlated with the 
total tumor area occupied by immune cells (r = 0.596 and 
r =  0.681, respectively, p  <  0.0005; Pearson), suggesting 
that especially the infiltration with T cells resulted in a 
larger immune to tumor cell ratio.
A larger immune infiltrate in patients with circulating 
proliferative HPV‑specific T cells
Among the group of 58 patients, 17 were previously 
tested for the presence of HPV-specific T cell reac-
tivity in the blood [4], 10 of whom were positive. The 
mean area occupied by CD45+ cells in the correspond-
ing tumors was larger in patients with a proliferative 
response than in the tumors of patients without such 
reactivity (Table 2). Similarly, the pixel count of tumor-
infiltrating Tbet+ cells was twofold higher in the group 
with a circulating HPV-specific T cell response, whereas 
the mean pixel count of Tregs or total cells did not differ 
(Table 2). Although the data were not statistically signifi-
cant in this small patient group, the results suggest that 
the detection of a proliferative response to HPV in the 
blood may be associated to a more active local immune 
response.
Fig. 1 Schematic representation of the automated quantitative method used. A representative image of a scanned slide (a). After deconvolut-
ing the haematoxylin (b) and DAB (c) colors, the total tissue area was selected using a 100 % threshold for the haematoxylin staining (d). Then the 
DAB positive area was determined (e). The number of pixels in image e was divided by the number of pixels in image d and multiplied by 100 to 
calculate the tumor percentage expressing DAB
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Fig. 2 Immunohistochemical staining for CD45, T-bet and FoxP3. Representative images of immunohistochemical stainings for CD45 (a, b), T-bet (c, 
d) and FoxP3 (e, f) are shown. On the left is a tumor sample with low lymphocyte frequencies and on the right a tumor sample with high lympho-
cyte frequencies (b, d, f). Images were obtained at a ×200 magnification
Page 6 of 10Gorter et al. J Transl Med  (2015) 13:295 
A large area with Tbet associated immune cell infiltrate 
prevents recurrences and improves disease specific 
survival
The known prognostic factors in CxCa are lymph 
node metastases (present or absent), tumor size (< or 
≥40  mm) and the invasion depth of the tumor in the 
surrounding cervical tissue (< or ≥15  mm) [5]. When 
the disease-free survival (DFS) and the disease specific 
survival (DSS) curves of the CxCa patients were plot-
ted based on these factors, the patients with lymph node 
metastases (p = 0.013; Log-Rank) and a tumor ≥40 mm 
(p  =  0.073; Log-Rank) were more prone to develop a 
recurrence (Fig. 3). While there were no differences with 
respect to the area occupied by immune cells, the pixel 
count of CD45+ cells or Foxp3+ cells, the pixel count of 
tumor-infiltrating Tbet+ cells was doubled in patients 
without lymph node metastases and with smaller tumors 
(Table 2). In addition, the DSS of patients was associated 
with the lymph node status (p  =  0.043; Log-Rank) but 
not with tumor size (p = 0.132; Log-Rank).
Then the DFS and DSS of the patients were plotted 
based on the four immune factors. The area occupied 
by CD45+ immune cells within the tumor was associ-
ated with a longer DFS (p  =  0.012; Log-Rank; Fig.  3) 
and DSS (p  =  0.016; Log-Rank). Notably, the larger 
CD45+ cell occupied areas comprised about threefold 
more Tbet+ cells and twofold more Foxp3+ cells than 
the smaller areas (Table 2) while the total pixel count of 
CD45+ cells increased marginally. This suggests that a 
relatively larger area of CD45+ cells within the tumor is 
the result of a more pronounced T-cell infiltration, irre-
spective of their functional phenotype, as no differences 
in the relative proportion of Tbet+ and Foxp3+ were 
found between tumors with relatively larger or smaller 
CD45+ cell areas (p =  0.947; Pearson). Next the group 
of patients was divided on the basis of infiltration with 
Tbet+ cells and Foxp3+ cells. Infiltration with Foxp3+ 
cells showed no association with DFS (p  =  0.69; Log-
Rank) or DSS (p = 0.24; Log-Rank). Similar results were 
obtained when Foxp3+ cell infiltration was analyzed as 
a ratio of the total numbers of CD45+ cells. A higher 
pixel count of tumor-infiltrating Tbet+ cells, however, 
was positively associated with DFS (p  =  0.024; Log-
Rank; Fig.  3) and DSS (p  =  0.009; Log-Rank). Also the 
ratio between the pixel count of Tbet+ cells and CD45+ 
cells showed a positive association with DFS (p = 0.029; 
Log-Rank) and DSS (p  =  0.019; Log-Rank), indicating 
that if more tumor-infiltrating immune cells display an 
IFNγ-associated phenotype, the risk of a recurrence or 
death due to CxCa is reduced. There was no difference 
in DFS or DSS when patients were divided according 
to the ratio of Foxp3+ cells and Tbet+ cells, indicating 
that the impact of Tbet+ cells does not depend on the 
co-infiltrating Tregs. This analysis confirms that the pres-
ence of a large area with IFNγ-positive cells (Tbet+) is 
associated with less recurrences and longer disease spe-
cific survival.
Immune infiltration is an independent prognostic factor 
for survival
Since the lymph node status is strongly associated with 
survival, we analyzed the DFS and DSS outcomes of 
the area occupied by CD45+ cells and the infiltration 
with Tbet+ cells in this context. Clearly the CD45 area 
(p  =  0.016; Log-Rank; Fig.  4) and the pixel count for 
Tbet+ cells (p = 0.009; Log-Rank; Fig. 4) had a positive 
effect on DSS, irrespectively of the lymph node status. 
A similar observation was made with respect to the area 
of CD45+ cells (p =  0.039; Log-Rank) and Tbet+ cells 
(p = 0.083; Log-Rank) with DFS. An interaction analysis 
(Additional file 1: Figure S1) based on the four categories 
formed by patients with absence or presence of lymph 
node metastases and a high or low pixel count for Tbet+ 
Table 2 Differences in  immune cell infiltration between   
groups
a Differences in means were assessed by independent sample t test, p < 0.05 is 
significant
b Within the current study group 17 patients have been tested for the presence 
of circulating HPV-specific T cells, 10 of them were negative [4]
c The area occupied by CD45 cells within the tumor was calculated as a 
percentage
d The pixel count of cells per high power field (20×) was analysed in 4 different 
fields
No Yes p valuea
Mean SEM Mean SEM
HPV-specific T cells in bloodb
 Area of CD45 cells (%) 9.76 2.51 15.47 2.93 0.203
 Total cell pixel count 5378 619 5678 377 0.667
 Tbet+ cells pixel count 244 72.0 434 185 0.485
 Foxp3+ cells pixel count 125 25.9 142 24.2 0.648
LN metastases present
 Area of CD45 cells (%)c 20 3.3 14 2.0 0.119
 Total cell pixel countd 5686 339 5655 183 0.942
 Tbet+ cells pixel countd 405 118 174 42 0.097
 Foxp3+ cells pixel countd 163 27.5 124 16.8 0.217
Tumor size ≥40 mm
 Area of CD45 cells (%) 20 3.4 16 2.5 0.346
 Total cell pixel count 5806 440 5590 189 0.656
 Tbet+ cells pixel count 488 162 189 40.6 0.087
 Foxp3+ cells pixel count 170 27.4 124 18.7 0.152
Area CD45 cells (%) ≥ median
 Total cell pixel count 5460 264 5919 279 0.239
 Tbet+ cells pixel count 114 27.9 328 55.0 0.002
 Foxp3+ cells pixel count 80.6 12.5 196 25.9 0.000
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cells confirmed the positive effect of Tbet+ cells for DFS 
(p =  0.032; Log-Rank) and DSS (p =  0.062; Log-Rank). 
The same was observed for the four groups based on 
lymph node status and a large or small area of CD45+ 
cells, showing that the area occupied by immune cells 
was a strong factor with respect to DFS (p = 0.014; Log-
Rank) and DSS (p = 0.083; Log-Rank).
Finally, a multivariate Cox analysis was performed 
in which the area occupied by CD45+ cells or the infil-
tration with Tbet+ cells were used as covariate besides 
lymph node status, the latter being the strongest clini-
cal pathological marker. Both the lymph node status and 
the immune infiltrate displayed a strong effect on DFS 
and DSS. Irrespective of the lymph node status, patients 
of whom the tumor displayed a relatively larger area 
with CD45+ cells had a lower risk for recurrences (HR 
0.300; CI 0.093–0.964; p = 0.043) and a lower risk to die 
of CxCa (HR 0.245; CI 0.065–0.924; p  =  0.038). Also, 
tumor-infiltration with higher pixel count for Tbet+ 
cells corresponded with a lower risk for recurrences (HR 
0.306; CI 0.084–1.109; p = 0.071) or to die of CxCa (HR 
0.175; CI 0.034–0.887; p =  0.035). Thus, the area occu-
pied by CD45+ cells or the infiltration with Tbet+ cells 
form two independent prognostic factors for recurrence-
free and disease-specific survival on top of the patient’s 
lymph node status.
Discussion
The presence of lymph node metastases, the tumor size 
and the deep penetration of the healthy surrounding tis-
sue by CxCa generally is associated with poor outcome 
[5]. In a previous study we detected systemic anti-tumor 
responses predominantly in patients with deep invading 
tumors and this was associated with a better disease free 
survival [4]. Here we zoomed in on the group of patients 
with deeply invading tumors. To obtain objective results, 
computer software was used to automatically quantify 


































































Fig. 3 Kaplan–Meier disease free survival curves. The patient group was divided based on two clinicopathological parameters (lymph node status 
or tumor size) or based on the three tested immune factors, the tumor area occupied by CD45+ cells, and the Tbet+ and Foxp3+ pixel count 
representing number of Tbet+ and Foxp3+ cells infiltrating the tumor, respectively. A Log-Rank test was used to determine whether the difference 
in disease free survival was significant
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of the percentage of tumor tissue occupied by CD45+ 
immune cells revealed a wide range within this group. 
Importantly, the area occupied by immune cells showed a 
positive correlation with recurrence free and disease spe-
cific survival. While the majority of the tumor infiltrating 
immune cells did not express Tbet or Foxp3, an increased 
immune percentage of tumor occupied by CD45+ cells 
was associated with the enhanced tumor-infiltration by 
Tbet+ cells and Foxp3+ cells. Notably, the mean and 
range of the number of infiltrating cells differed consider-
ably between the subtypes being the highest for CD45+ 
cells, followed by Tbet+ cells and the lowest for Foxp3+ 
cells. Furthermore, the correlation coefficients (r) in the 
Spearman’s rank test between the different cells ranged 
from 0.267 to 0.539. This indicates that while there is a 
tendency for different types of immune cells to simulta-
neously infiltrate the tumor this is not at a one-to-one 
basis and as such correlations between immune cell infil-
tration and clinical outcome not necessary overlap. Based 
on our earlier work a substantial amount of the infiltrat-
ing cells comprise different subsets of myeloid cells [12]. 
The Tbet+ cells are most likely IFNγ-producing T cells 
as NK cells have never been found in large numbers in 
CxCa [10]. Infiltration with Tbet+ cells but not Foxp3+ 
cells was also positively associated with DFS and DSS, 
indicating that the type 1 immune orientation of the infil-
trate, rather than the overall number of immune cells is 
an important predictor for the response to subsequent 
therapy. There are also indications that the dense infil-
tration with Tbet+ cells is associated with better clinical 
outcome in HPV-induced premalignant lesions [9, 17]. 
These data fit well with the role of IFNγ producing lym-
phocytes in the prevention and control of cancer cells in 





















































Fig. 4 Kaplan–Meier disease specific survival curves. The patient group was divided based on either the occupancy of the tumor area by CD45+ 
cells, or based on the Tbet+ pixel count representing the number of Tbet+ cells infiltrating. Disease specific survival was plotted (left two graphs). 
In addition, these two parameters were analyzed in the context of the lymph node status of the patient group. Log-Rank analysis was used to deter-
mine the statistical significance of the difference in disease specific survival
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type 1 T cells and improved response to therapy in ovar-
ian [21], colorectal [22], renal cell [23] and lung cancer 
[24].
Of the clinical pathological markers the lymph node 
status is an important predictor for the DFS and to a 
lesser extent for the DSS of patients with deep invad-
ing tumors. The tumors of patients without lymph node 
metastases on average had the largest area occupied with 
CD45+ immune cells and displayed a stronger infiltra-
tion with Tbet+ cells when compared to the tumors of 
patients with lymph node metastases. However, both 
immune parameters showed a significant impact on DFS 
and DSS irrespective of the lymph node status and these 
effects were retained in a multivariate Cox analysis.
Based on a study showing that in a wide variety of can-
cers the infiltrating Foxp3+ cells were functional Tregs 
[25], making it likely that the Foxp3+ cells detected in 
our study reflect Tregs. A high infiltration with Tregs 
has been associated with poor clinical outcome in ovar-
ian cancer [26] and breast cancer [27] but we did not find 
such a direct effect of the infiltrating Tregs in our study. 
Other studies on hepatocellular cancer [28] and CxCa 
[10] did not find a direct relation between Treg infiltra-
tion and clinical outcome, instead the ratio between 
CD8+ T cells and Tregs had prognostic value. However, 
the ratio between Tbet+ cells and Tregs did not change 
the DFS or DSS curves when compared to Tbet as a sin-
gle marker. Therefore, the clinical outcome of patients 
with deeply invading cervical tumors is not influenced 
by the Foxp3+ cells, which is also the case in glioma [29] 
and cutaneous melanoma [30].
The observation that the percentage of tumor area occu-
pied by immune cells—as measured by a simple objective 
quantitative automated method—showed a positive cor-
relation with recurrence free and disease specific survival 
opens up possibilities to use this technique in clinical man-
agement of the patients. One can envision that absolute 
cut-offs for the percentage of tumor occupied by immune 
cells can be defined to identify patients who do not benefit 
from the current standard therapy (low % occupied) or to 
select patients most likely to have a good clinical response 
upon immunotherapy. This will require validation of our 
conclusions in a larger dataset similar to what is done for 
the immunoscore in colorectal cancer [31].
Conclusions
Our previous study identified a subgroup of patients with 
cervical tumors deeply invading the surrounding normal 
tissue, who unexpectedly had a better outcome when 
they displayed an effector T-cell response against their 
tumor as evidenced by the presence of higher percentages 
of tumor-specific effector T cells and Tregs circulating 
in the blood [4]. By the use of an objective quantitative 
automated method that can readily be integrated in 
Pathology labs we confirmed that such a subgroup of 
patients with deeply tissue invading tumors displaying 
active tumor-immunity exists and that a strong type 1 
effector response within these tumors forms an impor-
tant prognostic factor for clinical outcome.
Authors’ contributions
AG and SB conceived and designed the study, interpreted the data and 
drafted the manuscript. FP and SP performed the immunostainings and 
image analyses. AG, MvD and SB performed the statistical analyses. All authors 
read and approved the final manuscript.
Author details
1 Department of Pathology, Leiden University Medical Center, Albinusdreef 
2, 2333 ZA Leiden, The Netherlands. 2 Department of Clinical Epidemiology, 
Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Neth-
erlands. 3 Department of Clinical Oncology, Leiden University Medical Center, 
Albinusdreef 2, 2333 ZA Leiden, The Netherlands. 
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 4 May 2015   Accepted: 7 September 2015
References
 1. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of 
cervicovaginal papillomavirus infection in young women. N Engl J Med. 
1998;338(7):423–8.
 2. Zur Hausen H. Papillomavirus infections—a major cause of human can-
cers. Biochimica et Biophysica Acta. 1996;1288:F55–78.
 3. van der Burg SH, Melief CJ. Therapeutic vaccination against human papil-
loma virus induced malignancies. Curr Opin Immunol. 2011;23(2):252–7.
 4. Heusinkveld M, Welters MJ, van Poelgeest MI, van der Hulst JM, Melief CJ, 
Fleuren GJ, et al. The detection of circulating human papillomavirus-spe-
cific T cells is associated with improved survival of patients with deeply 
infiltrating tumors. Int J Cancer. 2011;128(2):379–89.
 5. Singh N, Arif S. Histopathologic parameters of prognosis in cervical 
cancer–a review. Int J Gynecol Cancer. 2004;14(5):741–50.
 6. van Mierlo GJ, den Boer AT, Medema JP, van der Voort EI, Fransen MF, 
Offringa R, et al. CD40 stimulation leads to effective therapy of CD40(−) 
tumors through induction of strong systemic cytotoxic T lymphocyte 
immunity. Proc Natl Acad Sci USA. 2002;99(8):5561–6.
 7. Broderick L, Bankert RB. Memory T cells in human tumor and chronic 
inflammatory microenvironments: sleeping beauties re-awakened by a 
cytokine kiss. Immunol Invest. 2006;35(3–4):419–36.
 8. Zamarin D, Holmgaard RB, Subudhi SK, Park JS, Mansour M, Palese P, 
et al. Localized oncolytic virotherapy overcomes systemic tumor resist-
ance to immune checkpoint blockade immunotherapy. Sci Transl Med. 
2014;6(226):226ra32.
Additional file
Additional file 1: Figure S1. Interaction analysis of lymph node status 
and immune parameters. The patient group was divided based on the 
four categories formed by patients with absence/presence of lymph 
node metastases and a large/small area of CD45+ cells (left graphs) or a 
high/low pixel count for Tbet+ cells (right graphs). For these groups the 
Kaplan–Meier curves for disease specific survival (top row) and the recur-
rence free survival (bottom row) were plotted. Log-Rank analysis was used 
to determine the statistical significance of the difference in survival.
Page 10 of 10Gorter et al. J Transl Med  (2015) 13:295 
 9. Seresini S, Origoni M, Lillo F, Caputo L, Paganoni AM, Vantini S, et al. IFN-
gamma produced by human papilloma virus-18 E6-specific CD4+ T cells 
predicts the clinical outcome after surgery in patients with high-grade 
cervical lesions. J Immunol. 2007;179(10):7176–83.
 10. Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG, et al. 
Human leukocyte antigen class I, MHC class I chain-related molecule A, 
and CD8+/regulatory T-Cell ratio: which variable determines survival of 
cervical cancer patients? Clin Cancer Res. 2008;14(7):2028–35.
 11. Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der 
Hulst JM, Drijfhout JW, et al. High number of intraepithelial CD8+ tumor-
infiltrating lymphocytes is associated with the absence of lymph node 
metastases in patients with large early-stage cervical cancer. Cancer Res. 
2007;67(1):354–61.
 12. de Vos van Steenwijk PJ, Ramwadhdoebe TH, Goedemans R, Doorduijn 
EM, van Ham JJ, Gorter A, et al. Tumor-infiltrating CD14-positive myeloid 
cells and CD8-positive T-cells prolong survival in patients with cervical 
carcinoma. Int J Cancer. 2013;133(12):2884–94.
 13. Galon J, Angell HK, Bedognetti D, Marincola FM. The continuum of cancer 
immunosurveillance: prognostic, predictive, and mechanistic signatures. 
Immunity. 2013;39(1):11–26.
 14. Bontkes HJ, de Gruijl TD, Walboomers JM, van den Muysenberg AJ, 
Gunther AW, Scheper RJ, et al. Assessment of cytotoxic T-lymphocyte 
phenotype using the specific markers granzyme B and TIA-1 in cervical 
neoplastic lesions. Br J Cancer. 1997;76(10):1353–60.
 15. Karim R, Jordanova ES, Piersma SJ, Kenter GG, Chen L, Boer JM, et al. 
Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltra-
tion and survival of patients with cervical carcinoma. Clin Cancer Res. 
2009;15(20):6341–7.
 16. Badoual C, Hans S, Merillon N, Van Ryswick C, Ravel P, Benhamouda N, 
et al. PD-1-expressing tumor-infiltrating T cells are a favorable prog-
nostic biomarker in HPV-associated head and neck cancer. Cancer Res. 
2013;73(1):128–38.
 17. van Esch EM, van Poelgeest MI, Kouwenberg S, Osse EM, Trimbos JB, 
Fleuren GJ, et al. Expression of coinhibitory receptors on T cells in the 
microenvironment of usual vulvar intraepithelial neoplasia is related 
to proinflammatory effector T cells and an increased recurrence-free 
survival. Int J Cancer. 2015;136(4):E95–106.
 18. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev 
Immunol. 2005;5(12):953–64.
 19. Stoler M, Bergeron C, Colgan TJ, Ferenczy AS, Herrington CS, Kim K-R, et al. 
Epithelial tumours, part of tumours of the uterine cervix, chapter 7. In: 
Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classifi-
cation of tumours of female reproductive organs. 4th ed. IARC: Lyon;2014. 
p.172–98.
 20. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, et al. 
IFNgamma and lymphocytes prevent primary tumour development and 
shape tumour immunogenicity. Nature. 2001;410(6832):1107–11.
 21. Marth C, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Doppler W, et al. 
Interferon-gamma expression is an independent prognostic factor in 
ovarian cancer. Am J Obstet Gynecol. 2004;191(5):1598–605.
 22. Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, et al. 
Clinical impact of different classes of infiltrating T cytotoxic and helper 
cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res. 
2011;71(4):1263–71.
 23. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Osaka Y, Futatsuyama K, et al. 
Favorable prognosis of renal cell carcinoma with increased expression of 
chemokines associated with a Th1-type immune response. Cancer Sci. 
2006;97(8):780–6.
 24. Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, et al. 
Long-term survival for patients with non-small-cell lung cancer with 
intratumoral lymphoid structures. J Clin Oncol. 2008;26(27):4410–7.
 25. Kryczek I, Liu R, Wang G, Wu K, Shu X, Szeliga W, et al. FOXP3 defines 
regulatory T cells in human tumor and autoimmune disease. Cancer Res. 
2009;69(9):3995–4000.
 26. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific 
recruitment of regulatory T cells in ovarian carcinoma fosters immune 
privilege and predicts reduced survival. Nat Med. 2004;10(9):942–9.
 27. Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, et al. Quanti-
fication of regulatory T cells enables the identification of high-risk 
breast cancer patients and those at risk of late relapse. J Clin Oncol. 
2006;24(34):5373–80.
 28. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, et al. Intratumoral balance 
of regulatory and cytotoxic T cells is associated with prognosis of hepato-
cellular carcinoma after resection. J Clin Oncol. 2007;25(18):2586–93.
 29. Heimberger AB, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Sun W, Qiao W, 
et al. Incidence and prognostic impact of FoxP3+ regulatory T cells in 
human gliomas. Clin Cancer Res. 2008;14(16):5166–72.
 30. Hillen F, Baeten CI, van de Winkel A, Creytens D, van der Schaft DW, Win-
nepenninckx V, et al. Leukocyte infiltration and tumor cell plasticity are 
parameters of aggressiveness in primary cutaneous melanoma. Cancer 
Immunol Immunother. 2008;57(1):97–106.
 31. Anitei MG, Zeitoun G, Mlecnik B, Marliot F, Haicheur N, Todosi AM, et al. 
Prognostic and predictive values of the immunoscore in patients with 
rectal cancer. Clin Cancer Res. 2014;20(7):1891–9.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
